A Systematic Review and Meta-Analysis of the R778L Mutation in ATP7B with Wilson Disease in China

Ziru Xue,Hongyu Chen,Yu Liu,Peifang Jiang
DOI: https://doi.org/10.1016/j.pediatrneurol.2023.04.026
IF: 4.21
2023-01-01
Pediatric Neurology
Abstract:Background Wilson disease (WD) is a hereditary disorder of copper metabolism, caused by mutations in the ATP7B gene. There are more than 1000 pathogenic variants identified in ATP7B. R778L is the most common ATP7B mutation in China. Methods To estimate whether R778L is associated with the onset age of WD and other clinical variables. Genotyping results of ATP7B gene were collected in our 22 patients with WD. We then conducted a systematic review and meta-analysis in databases, using the keywords Wilson disease and R778L mutation. Results After the screening, a total of 23 studies were included, including 3007 patients with WD. Patients with R778L mutation presented at an earlier age (standardized mean difference [SMD] = −0.18 [95% confidence interval, −0.28 to 0.08], P = 0.0004) and had lower ceruloplasmin concentration (SMD = −0.21 [95% confidence interval, −0.40 to −0.02], P = 0.03) than the patients without the R778L mutation. However, sex (odds ratio [OR] = 1.07 [95% confidence interval, 0.89 to 1.29], P = 0.32) and first presentation were not associated with R778L mutation in WD (hepatic: OR = 1.37 [95% confidence interval, 0.87 to 2.16, P = 0.17; neurological: OR = 0.79 [95% confidence interval, 0.48 to 1.30, P = 0.35; mix: OR = 1.04 [95% confidence interval, 0.42 to 2.53, P = 0.87; asymptomatic/others: OR = 1.98 [95% confidence interval, 0.49 to 7.96, P = 0.34). Conclusions Our results indicated that the R778L mutation is associated with an earlier presentation and lower ceruloplasmin concentration in China.
What problem does this paper attempt to address?